U.S. Trade Distributors Stock News

NYSE:RHLD
NYSE:RHLDProfessional Services

A Look At Resolute Holdings Management (RHLD) Valuation After Strong 1-Year Returns And Recent Share Price Weakness

Recent price moves set the stage Resolute Holdings Management (RHLD) has drawn attention after a recent stretch of weaker trading, with the share price down about 10% over the past week and 17% over the past month. See our latest analysis for Resolute Holdings Management. Those short term share price declines sit against a very different longer term picture, with the 1 year total shareholder return around 260%, suggesting earlier buyers have still seen very strong gains despite fading recent...
NasdaqGS:GH
NasdaqGS:GHHealthcare

Guardant Health Acquisition Spurs Inducement Grants And Draws Investor Attention

Guardant Health (NasdaqGS:GH) granted significant inducement equity awards to new employees under its 2023 Employment Inducement Incentive Award Plan following the acquisition of a competitor. The company’s role as a key performance contributor was recently highlighted by the Aristotle Growth Equity Fund, which pointed to the acquisition and robust revenue growth as important drivers. These developments reflect material changes in Guardant Health’s team structure and market positioning that...
NasdaqGS:INTU
NasdaqGS:INTUSoftware

Intuit (INTU) Margin Expansion Tests Bearish Spending Narratives After Q2 2026 Results

Intuit (INTU) has put solid numbers on the board for Q2 2026, with revenue of US$4.7b, basic EPS of US$2.48 and net income of US$693m, backed by trailing 12 month EPS of US$15.53 on revenue of US$20.1b. The company has seen quarterly revenue shift from US$3.9b in Q2 2025 to US$4.7b in Q2 2026, while basic EPS moved from US$1.68 to US$2.48 over the same period. This sets the context for trailing earnings growth of 42.9% and a net margin of 21.6%. For investors, the combination of higher recent...
NasdaqGS:FSLY
NasdaqGS:FSLYIT

Fastly’s AI Edge Pivot Links New Profitability With Rising Security Stakes

Fastly (NasdaqGS:FSLY) has emerged as a key player in AI and edge computing, highlighting its role in supporting AI-first applications at the network edge. The company has reached a new profitability milestone after a history of losses, signaling a shift in how its edge cloud platform is being used and monetized. Fastly released a new Global Security Research Report that focuses on cyber risks facing AI-first businesses, calling out rising threats around data integrity, model abuse, and edge...
NYSE:ENOV
NYSE:ENOVMedical Equipment

Enovis Weighs US$501.3m Impairment Against Nebula Led Organic Growth

Enovis (NYSE:ENOV) recorded a goodwill impairment charge of over $500 million in Q4 2025, tied to changes in its business mix and accounting assumptions. The company reported strong organic growth in key segments in the same period, supported by new product launches. Recently introduced products, including the Nebula Stem and OrthoDrive Impactor, are gaining traction, with Nebula competing directly against established peers. For investors tracking Enovis, the combination of a large goodwill...
NasdaqGS:MMSI
NasdaqGS:MMSIMedical Equipment

Merit Medical’s Expansion Push Tests Acquisition Execution And Growth Targets

Merit Medical Systems, NasdaqGS:MMSI, has launched its "Continued Growth Initiatives" Program with multi-year company-wide targets. The company recently completed the merger with Biolife Delaware, expanding its capabilities in interventional medical products. Merit Medical Systems also acquired the C2 CryoBalloon device, adding a new technology platform to its product portfolio. Merit Medical Systems, trading around $77.18, comes into these new moves after a mixed stretch for shareholders...
NYSE:BBWI
NYSE:BBWISpecialty Retail

Bath And Body Works Expands On Amazon As Valuation Gap Persists

Bath & Body Works (NYSE:BBWI) has launched its first authorized storefront on Amazon's U.S. platform. The company introduced an updated brand identity for its core business. Bath & Body Works also rolled out a spring product collaboration with PEEPS. For Bath & Body Works, a retailer focused on fragrances, body care, and home scents, being officially available on Amazon places its products in front of a broader online audience. The refreshed brand identity comes at a time when many consumer...
NasdaqGS:MGNI
NasdaqGS:MGNIMedia

Magnite (MGNI) Valuation After Strong CTV Results And New US$200 Million Share Buyback Program

Magnite (MGNI) is back in focus after reporting fourth quarter and full year 2025 results, alongside a new US$200 million share repurchase plan that puts capital allocation and Connected TV growth firmly on investors’ radar. See our latest analysis for Magnite. The market reaction has been mixed around the earnings and buyback news, with a 7 day share price return of 11.37%, a year to date share price return decline of 15.19%, and a 5 year total shareholder return decline of 65.17%,...
NYSE:IONQ
NYSE:IONQTech

IonQ (IONQ) Is Up 20.3% After Record 2025 Revenue And Major Romania Deal News - Has The Bull Case Changed?

In late February 2026, IonQ reported very large year-on-year revenue growth to US$61.89 million for the fourth quarter and US$130.02 million for 2025, issued higher-than-expected 2026 revenue guidance of US$225 million to US$245 million, and announced plans to expand via acquisitions and equity issuance. A key operational highlight was IonQ’s role powering Romania’s new national quantum key distribution network, one of Europe’s largest, which showcases real-world demand for its...
NasdaqGS:INVA
NasdaqGS:INVAPharmaceuticals

Is It Too Late To Consider Innoviva (INVA) After Its Strong Multi‑Year Share Price Run?

If you are wondering whether Innoviva's current share price still offers value after a strong run, this article walks through what the numbers are actually saying about the stock. Over the short term the stock has been mixed, with a 1.8% decline over the last 7 days. It currently sits at US$22.96 after returns of 17.4% over 30 days, 15.6% year to date, 28.1% over 1 year and 108.9% over 3 years, with a 99.5% return over 5 years. Recent coverage around Innoviva has focused on its positioning...
NYSE:WKC
NYSE:WKCOil and Gas

World Kinect’s Widening Losses and Paused Buybacks Could Be A Game Changer For World Kinect (WKC)

In February 2026, World Kinect Corporation reported that fourth quarter 2025 sales fell to US$9,029 million from US$9,760.5 million a year earlier, with the quarterly net loss widening to US$279.7 million and full-year 2025 sales declining to US$36.92 billion alongside a US$614.4 million net loss. The company also disclosed that, by December 31, 2025, it had repurchased 1,923,892 shares for US$47.89 million under a prior buyback plan, while undertaking no repurchases under a newer December...
NYSE:VVV
NYSE:VVVSpecialty Retail

Is It Too Late To Reassess Valvoline (VVV) After Its Strong Year To Date Run?

Investors may be wondering whether Valvoline at around US$37.80 is offering good value right now or if the recent attention has already been priced in. The share price has had mixed returns, with a 2.4% decline over the last 7 days, a 15.1% gain over 30 days, a 30.9% return year to date, 2.5% over 1 year and 52.4% over 5 years. Recent coverage has focused on Valvoline as a standalone retail services business and how investors are reassessing pure play auto service models. Headlines have...
NasdaqGS:CHYM
NasdaqGS:CHYMDiversified Financial

Chime Financial Expands Workplace Platform And MLS Deal To Tackle Losses

Chime Financial (NasdaqGS:CHYM) is expanding its Chime Workplace offering as more large employers adopt its financial wellness platform. The company has entered a multi year partnership with Major League Soccer as the Official Retail Banking, Credit Card, and Debit Card Partner of the league. Chime Financial is stepping further into enterprise services through Chime Workplace, adding a new leg to a business that many investors still view mainly as a consumer focused fintech app. The stock...
NYSE:TOL
NYSE:TOLConsumer Durables

How Toll Brothers’ Luxury Community Push and Design Accolades Will Impact Toll Brothers (TOL) Investors

In late February 2026, Toll Brothers announced several luxury community milestones, including the upcoming Toll Brothers at Audubon in Magnolia, Texas, and the final condo building release at New Talley Station in Decatur, Georgia, alongside other high-end developments across Texas, Nevada, South Carolina, and beyond. These launches, combined with recent industry awards and recognition for design and brand strength, underscore how Toll Brothers is concentrating its pipeline in affluent,...
NYSE:RAMP
NYSE:RAMPSoftware

A Look At LiveRamp Holdings (RAMP) Valuation As Shares Rebound In The Short Term

Event overview and why LiveRamp matters now LiveRamp Holdings (RAMP) is back on investors’ radar after recent share price moves, with the stock showing a mix of positive short term returns and weaker performance over the past year and five years. See our latest analysis for LiveRamp Holdings. LiveRamp’s recent 7 day share price return of 5.97% and 30 day share price return of 9.42% contrasts with a 1 year total shareholder return decline of 9.07%, which may indicate that short term momentum...
NYSE:TWO
NYSE:TWOMortgage REITs

UWM Deal Adds Uncertainty To Two Harbors Valuation And Dividend Outlook

UWM Holdings has agreed to acquire Two Harbors Investment Corp (NYSE:TWO), creating fresh questions for mortgage and mortgage servicing investors. Management at UWM has offered limited detail on how Two Harbors will be integrated, including capital allocation, portfolio positioning, and leadership roles. Investors are reacting to sparse guidance around timing, financial impact, and operational changes, especially given existing financial pressures at Two Harbors. Two Harbors focuses on...
NasdaqGS:COCO
NasdaqGS:COCOBeverage

Assessing Vita Coco (COCO) Valuation After Mixed Quarter And Confident 2026 Guidance

Vita Coco Company (COCO) is back in focus after its latest quarter showed revenue ahead of expectations, while earnings per share came in slightly below consensus, alongside fresh guidance for fiscal 2026. See our latest analysis for Vita Coco Company. At a share price of $58.06, Vita Coco has seen positive momentum recently, with a 7 day share price return of 7.60% and a 90 day share price return of 8.71%, while its 1 year total shareholder return of 78.98% and 3 year total shareholder...
NYSE:YOU
NYSE:YOUSoftware

Clear Secure (YOU) Is Up 41.9% After Strong Cash Returns And Healthcare Push Has The Bull Case Changed?

Earlier this week, Clear Secure reported fourth-quarter and full-year 2025 results showing higher sales year over year, issued first-quarter 2026 revenue guidance of US$242–US$245 million, and announced both a 20% increase in its regular quarterly dividend to US$0.15 per share and a special US$0.20 per-share dividend alongside an expanded share repurchase authorization. The company also highlighted strong free cash flow generation, renewed its multiyear partnership with American Express, and...
NYSE:KD
NYSE:KDIT

Has Kyndryl (KD) Fallen Too Far After IBM Separation To Ignore Its Valuation?

If you have been wondering whether Kyndryl Holdings is starting to look like value or a value trap, this article walks through the numbers so you can judge that for yourself. The stock last closed at US$12.33, with returns of 1.4% decline over 7 days, 48.0% decline over 30 days, 51.6% decline year to date and 67.6% decline over 1 year. This naturally raises questions about how the market is currently pricing the business. Recent news around Kyndryl has focused on its position as a standalone...
NasdaqCM:NEXT
NasdaqCM:NEXTOil and Gas

Does EQT Offtake Deal and Rio Grande LNG Progress Change The Bull Case For NextDecade (NEXT)?

NextDecade is preparing to report its fourth-quarter results on March 2, 2026, as it works to bring the Rio Grande LNG facility online while managing ongoing losses. A recent 20-year offtake agreement with EQT for 1.5 million tonnes per annum stands out as a key milestone in de-risking future LNG sales from the project. We’ll now examine how progress at Rio Grande LNG, including the EQT offtake deal, is shaping NextDecade’s broader investment narrative. Capitalize on the AI infrastructure...
NasdaqGS:UTHR
NasdaqGS:UTHRBiotechs

United Therapeutics Tresmi Launch And Record Revenue Shape Valuation Debate

United Therapeutics unveiled its new Tresmi soft mist inhaler platform, designed to improve patient experience in pulmonary hypertension treatment. The company reported record annual revenue alongside the Tresmi launch, underscoring progress across its commercial portfolio. Management also highlighted advances in late stage clinical programs, pointing to several upcoming trial readouts as key catalysts. United Therapeutics, traded as NasdaqGS:UTHR, comes into this news with a share price of...
NasdaqGS:MBLY
NasdaqGS:MBLYAuto Components

Mobileye Deepens ADAS Partnerships And Moves Closer To Level 4 Scale

Mobileye Global (NasdaqGS:MBLY) is adding Elektrobit’s Linux platform to its Mobileye Drive system to support Level 4 autonomous driving. The company recently secured a major U.S. OEM win for its advanced driver assistance systems, expanding its ADAS pipeline. Mobileye signed a SuperVision agreement with Mahindra & Mahindra, positioning itself as a Tier 1 supplier and opening new geographic markets. Mobileye Global, known for its driver assistance and autonomous driving technology, is...
NasdaqGS:AVAH
NasdaqGS:AVAHHealthcare

Is Aveanna Healthcare Holdings (AVAH) Still Attractively Priced After Its Recent Multi Year Surge

If you are wondering whether Aveanna Healthcare Holdings is still attractively priced after its recent run, you are not alone. This article focuses on what the current share price could imply about value. The stock last closed at US$7.36, with returns of 0.3% over 7 days, a 10.8% decline over 30 days, an 8.9% decline year to date, and a 72.8% gain over the past year, as well as a very large 3 year return of around 4x. Recent coverage has centred on Aveanna's role in home and pediatric...
NasdaqGS:JAZZ
NasdaqGS:JAZZPharmaceuticals

Jazz Pharmaceuticals (JAZZ) Is Up 10.4% After Record Q4 Revenue And New Oncology Data Release

In late February 2026, Jazz Pharmaceuticals reported fourth‑quarter 2025 revenue of US$1,197.93 million and net income of US$203.45 million, contributing to record full‑year revenue of US$4.27 billion but a net loss of US$356.15 million. The company paired these results with guidance for 2026 revenue of US$4.25–4.50 billion and highlighted practice‑changing oncology data for zanidatamab and Ziihera, reinforcing its rare‑disease and cancer focus despite full‑year losses. Next, we’ll examine...